Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) issued its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.45) EPS for the quarter, topping analysts’ consensus estimates of ($1.64) by $0.19, Briefing.com reports. Agios Pharmaceuticals had a negative return on equity of 38.08% and a negative net margin of 1,312.64%. The company had revenue of […]
Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its target price raised by The Goldman Sachs Group from $29.00 to $33.00 in a report issued on Friday morning, Benzinga reports. The firm currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts have also commented on AGIO. JPMorgan Chase & Co. reduced […]
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) had its price target hoisted by equities researchers at The Goldman Sachs Group from $29.00 to $33.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “neutral” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s price target indicates a potential downside of […]
Investment Analysts’ price target changes for Friday, May 3rd: Apple (NASDAQ:AAPL) had its target price increased by Monness Crespi & Hardt from $200.00 to $205.00. The firm currently has a buy rating on the stock. Apple (NASDAQ:AAPL) had its target price boosted by JPMorgan Chase & Co. from $210.00 to $225.00. They currently have an […]